Abstract:Objective: To investigate the effect and tolerance of non-invasive ventilation (NIV) with helmet in patients with respiratory failure caused by acute exacerbation of chronic obstructive pulmonary disease (AECOPD) and the effect on improving blood gas, alleviating dyspnea and the occurrence of complications. Methods: Patients with AECOPD and respiratory failure admitted to emergency intensive care unit (EICU) and respiratory intensive care unit (RICU) of the First Affiliated Hospital of Zhengzhou University from January 1st, 2018 to May 31st, 2019 were enrolled. After obtaining the informed consent of the patients or their authorized family members, the patients were divided into two groups: the helmet group and the facial mask group by random number table. NIV was carried out by using helmet or facial mask, respectively. During the course of NIV (immediately, 1 hour, 4 hours and at the end of NIV), the tolerance score, blood gas analysis, heart rate (HR), respiratory rate (RR) of patients were monitored, and the incidence of tracheal intubation, in-hospital mortality and complications were observed. Kaplan-Meier survival curve was plotted to analyze the 30-day cumulative survival of the two groups. Results: A total of 82 patients with AECOPD and respiratory failure were included during the study period. After excluding patients with the oxygenation index (PaO2/FiO2) > 200 mmHg (1 mmHg = 0.133 kPa), with tracheal intubation or invasive ventilation, suffering from acute myocardial infarction, severe trauma within 2 weeks, excessive secretion, sputum discharge disorder or refusal to participate in the study, 26 patients were finally enrolled in the analysis, randomly assigned to the helmet group and the facial mask group, with 13 patients in each group. The PaO2/FiO2 after NIV of patients in both groups was increased significantly as compared with that immediately after NIV, without significant difference between the two groups, but the increase in PaO2/FiO2 at the end of NIV compared with immediately after NIV in the helmet group was significantly higher than that in the facial mask group (mmHg: 75.1±73.2 vs. 7.7±86.0, P < 0.05). RR at each time point after NIV in the two groups was lower than that immediately after NIV, especially in the helmet group. There were significant differences between the helmet group and facial mask group at 1 hour, 4 hours, and the end of NIV (times/min: 17.5±4.1 vs. 23.1±6.3 at 1 hour, 16.2±2.5 vs. 20.0±5.5 at 4 hours, 15.5±2.5 vs. 21.2±5.9 at the end of NIV, all P < 0.05). The NIV tolerance score of the helmet group at 4 hours and the end was significantly higher than that of the facial mask group (4 hours: 3.9±0.3 vs. 3.3±0.9, at the end of NIV: 3.8±0.6 vs. 2.9±0.9, both P < 0.05). There was no significant difference in the improvement of pH value, arterial partial pressure of carbon dioxide (PaCO2), or HR between helmet group and facial mask group. The total number of complications (cases: 3 vs. 8) and the nasal skin lesions (cases: 0 vs. 4) in the helmet group were significantly less than those in the facial mask group (both P < 0.05). Only 2 patients in the helmet group received endotracheal intubation, and 1 of them died; 5 patients in the facial mask group received endotracheal intubation, and 3 of them died; there was no significant difference between the two groups (both P > 0.05). The Kaplan-Meier survival curve analysis showed that the cumulative survival rate of 30 days in the helmet group was lower than that in the facial mask group, but the difference was not statistically significant (Log-Rank test: χ2 = 1.278, P = 0.258). Conclusions: NIV with helmet has better comfort for patients with AECOPD combined with respiratory failure, and better effect on improving oxygenation and relieving dyspnea, and its effect on carbon dioxide emissions is not inferior to that of traditional mask NIV.

Noninvasive Ventilation with Complex Critical Care Ventilator in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Evaluation of the Effectivenesss of Noninvasive Positive Pressure Ventilation As a Weaning Strategy in Patients with Acute Respiratory Failure

The Comparison Between the Continual Positive Airway Pressure Ventilation and the Bilevel Positive Airway Pressure Ventilation in Treating Acute Cardiogenic Pulmonary Edema

Efficacy and Impact on Serum Matrix Metalloproteinase-9 of Long-Term Non-Invasive Positive Pressure Ventilation Combined with Inhaling Corticosteroids in Patients with Stable Severe Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

A Survey of the Practice of Non-Invasive Positive Pressure Ventilation in Emergency Department in China

[Prospective Randomized Controlled Clinical Study of Early Use of Noninvasive Positive Pressure Ventilation in the Treatment for Acute Exacerbation of Chronic Obstructive Pulmonary Disease].

Early Use Of Noninvasive Techniques For Clearing Respiratory Secretions During Noninvasive Positivepressure Ventilation In Patients With Acute Exacerbation Of Chronic Obstructive Pulmonary Disease And Hypercapnic Encephalopathy

Clinical efficacy of HI-NPPV in the treatment of AECOPD combined with severe type II respiratory failure

Efficacy and Safety of Noninvasive Positive Pressure Ventilation in the Patients with Respiratory Failure Due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Conscious Disturbances

Efficacy of Non-invasive Bi-level Positive Airway Pressure Ventilation in the Patients with Type Ⅱ Respiratory Failure due to Acute Exacerbation of Chronic Obstructive Pulmonary Disease

A Comparison Of Synchronized Intermittent Mandatory Ventilation And Pressure-Regulated Volume Control Ventilation In Elderly Patients With Acute Exacerbations Of Copd And Respiratory Failure

Optimal Time of the Use of Non-Invasive Positive Pressure Ventilation on Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Respiratory Failure

Observation on the Effect of Non-Invasive Ventilator Combined with Conventional Therapy in the Treatment of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Noninvasive Ventilator in the Old AECOPD Combination of Respiratory Failure the Clinical Value

P146 the Patients with Acute Exacerbation of COPD Maybe Benefit from Autotitrating EPAP During Noninvasive Ventilation: a Prospective Study

[Comparative study on pros and cons of sequential high-flow nasal cannula and non-invasive positive pressure ventilation immediately following early extubated patients with severe respiratory failure due to acute exacerbations of chronic obstructive pulmonary disease]

Relevant Factors Which Influence Effects of Noninvasive Positive Pressure Ventilation on Severe COPD Patients with Respiratory Failure

Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease

Clinical study of NFNC in the treatment of acute exacerbation chronic obstructive pulmonary disease patients with respiratory failure

[Non-invasive ventilation with helmet in patients with respiratory failure caused by acute exacerbation of chronic obstructive pulmonary disease]

Outcome of different modes of non-invasive ventilation in chronic obstructive pulmonary disease patients with type II respiratory failure